Robert A. Koshgarian
Directeur des opérations chez Vizgen, Inc.
Profil
Mr. Koshgarian has years of experience in the medical device industry in various senior-level R&D and Manufacturing roles at Haemonetics Corporation, CytoLogix Corporation and ViaCell, Inc. He was most recently the Vice President of Operations at ViaCell.
Mr. Koshgarian received his BS in Electrical Engineering from Brown University, an MS in Electrical Engineering from the University of Utah and an MBA from Harvard Business School.
Postes actifs de Robert A. Koshgarian
| Sociétés | Poste | Début |
|---|---|---|
Vizgen, Inc.
 Vizgen, Inc. BiotechnologyHealth Technology Vizgen, Inc. engages in business of biotechnology. The company was founded in 2019 and is headquartered in Cambridge, MA. | Directeur des opérations | 26/07/2021 |
Anciens postes connus de Robert A. Koshgarian
| Sociétés | Poste | Fin |
|---|---|---|
Kairos Partners
 Kairos Partners Investment ManagersFinance Founded in 2000, Kairos Partners is a private equity firm located in Norwell, Massachusetts. | Private Equity Investor | 01/04/2008 |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Cytologix Corp.
 Cytologix Corp. Miscellaneous Commercial ServicesCommercial Services The number of people suffering from cancer is constantly growing. A key factor in ensuring patients the best treatment is to make an accurate and full diagnosis and choose the right form of treatment at an early stage. At Dako it builds its business to constantly improve cancer diagnostics. The pathology lab is where all cancer related diagnoses are being prepared and where they have its main focus. By focusing on the entire workflow of the pathology labs worldwide they believe that they can contribute in improving quality, safety and cost efficiency for the benefit of the doctors, the lab and especially the patients waiting for results. The strategic focus of Dako is centered on workflow in the pathology laboratory with the aim of: 1. Reducing time from biopsy to diagnosis 2. Improving quality and reliability of the diagnosis 3. Reducing laboratory costs. The company goal is to help its customers help their patients the most human way possible. They work closely with doctors and experts in the field of cancer diagnostics to ensure they stay at the forefront of their needs and the market development. Partnering is a way for to get access to relevant technologies outside its own core competencies. They aim to be an attractive partner and employer and have a highly trained and skilled international staff to develop, manufacture and market its products all over the world. Its organization is spread world wide. They stay in close relations and support openness and dialogue as an important element in the way they work. Dako is a global business with headquarters in Denmark. It was founded by the Danish medical doctor Niels Harboe in 1966 and has more than 40 years' experience in the development and production of reagents and antibodies. | Corporate Officer/Principal | - |
| HAEMONETICS CORPORATION | Corporate Officer/Principal | - |
Formation de Robert A. Koshgarian
| Brown University | Undergraduate Degree |
| University of Utah | Graduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HAEMONETICS CORPORATION | Health Technology |
| Entreprise privées | 4 |
|---|---|
Kairos Partners
Kairos Partners Investment ManagersFinance Founded in 2000, Kairos Partners is a private equity firm located in Norwell, Massachusetts. | Finance |
Cytologix Corp.
Cytologix Corp. Miscellaneous Commercial ServicesCommercial Services The number of people suffering from cancer is constantly growing. A key factor in ensuring patients the best treatment is to make an accurate and full diagnosis and choose the right form of treatment at an early stage. At Dako it builds its business to constantly improve cancer diagnostics. The pathology lab is where all cancer related diagnoses are being prepared and where they have its main focus. By focusing on the entire workflow of the pathology labs worldwide they believe that they can contribute in improving quality, safety and cost efficiency for the benefit of the doctors, the lab and especially the patients waiting for results. The strategic focus of Dako is centered on workflow in the pathology laboratory with the aim of: 1. Reducing time from biopsy to diagnosis 2. Improving quality and reliability of the diagnosis 3. Reducing laboratory costs. The company goal is to help its customers help their patients the most human way possible. They work closely with doctors and experts in the field of cancer diagnostics to ensure they stay at the forefront of their needs and the market development. Partnering is a way for to get access to relevant technologies outside its own core competencies. They aim to be an attractive partner and employer and have a highly trained and skilled international staff to develop, manufacture and market its products all over the world. Its organization is spread world wide. They stay in close relations and support openness and dialogue as an important element in the way they work. Dako is a global business with headquarters in Denmark. It was founded by the Danish medical doctor Niels Harboe in 1966 and has more than 40 years' experience in the development and production of reagents and antibodies. | Commercial Services |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Health Technology |
Vizgen, Inc.
Vizgen, Inc. BiotechnologyHealth Technology Vizgen, Inc. engages in business of biotechnology. The company was founded in 2019 and is headquartered in Cambridge, MA. | Health Technology |